|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.020 EUR | 0.00% |
|
+1.62% | -8.06% |
| Jul. 18 | Garofalo Health Care Acquires Casa di Cura Città di Roma | AN |
| Jul. 18 | Garofalo Health Care buys Casa di Cura Citta' di Roma | RE |
Company Valuation: Garofalo Health Care S.p.A.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 433.4 | 491.1 | 327.4 | 411 | 483.6 | 444.1 | - | - |
| Change | - | 13.32% | -33.34% | 25.54% | 17.65% | -8.16% | - | - |
| Enterprise Value (EV) 1 | 531.1 | 633.5 | 472.4 | 616.7 | 688.1 | 636.1 | 620.1 | 587.1 |
| Change | - | 19.29% | -25.43% | 30.55% | 11.56% | -7.55% | -2.52% | -5.32% |
| P/E ratio | 37.9x | 26.2x | 15.3x | 25.8x | 22.8x | 16.7x | 15.4x | 14.8x |
| PBR | 2.34x | 1.88x | 1.17x | 1.37x | 1.5x | 1.32x | 1.26x | 1.17x |
| PEG | - | 0.5x | 1.1x | -1x | 0.7x | 0.7x | 1.85x | 3.44x |
| Capitalization / Revenue | 2.06x | 1.73x | 1.01x | 1.11x | 1.03x | 0.92x | 0.91x | 0.89x |
| EV / Revenue | 2.52x | 2.23x | 1.46x | 1.67x | 1.46x | 1.32x | 1.27x | 1.18x |
| EV / EBITDA | 15.6x | 11.9x | 8.06x | 9.19x | 8.77x | 7.7x | 7.15x | 6.6x |
| EV / EBIT | 34.3x | 22.4x | 14.9x | 15.7x | 15.6x | 12.6x | 11.6x | 10.7x |
| EV / FCF | 123x | 54.4x | 16.3x | - | 51.3x | 20.1x | 15.9x | 14.1x |
| FCF Yield | 0.81% | 1.84% | 6.12% | - | 1.95% | 4.98% | 6.31% | 7.09% |
| Dividend per Share 2 | - | - | - | - | - | 0.09 | 0.097 | 0.102 |
| Rate of return | - | - | - | - | - | 1.79% | 1.93% | 2.03% |
| EPS 2 | 0.14 | 0.21 | 0.24 | 0.18 | 0.24 | 0.3 | 0.325 | 0.339 |
| Distribution rate | - | - | - | - | - | 30% | 29.8% | 30.1% |
| Net sales 1 | 210.8 | 283.7 | 322.6 | 368.7 | 470.7 | 481 | 489 | 498 |
| EBITDA 1 | 34 | 53.1 | 58.6 | 67.1 | 78.5 | 82.6 | 86.7 | 89 |
| EBIT 1 | 15.49 | 28.23 | 31.66 | 39.23 | 44.13 | 50.4 | 53.3 | 54.8 |
| Net income 1 | 11.78 | 18.83 | 21.43 | 20.8 | 21.7 | 26.6 | 28.9 | 30.1 |
| Net Debt 1 | 97.69 | 142.4 | 145 | 205.7 | 204.5 | 192 | 176 | 143 |
| Reference price 2 | 5.300 | 5.500 | 3.680 | 4.640 | 5.460 | 5.020 | 5.020 | 5.020 |
| Nbr of stocks (in thousands) | 81,773 | 89,298 | 88,966 | 88,578 | 88,563 | 88,466 | - | - |
| Announcement Date | 3/16/21 | 3/16/22 | 3/16/23 | 3/14/24 | 3/14/25 | - | - | - |
1EUR in Million2EUR
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 16.73x | 1.32x | 7.7x | - | 518M | ||
| 28.37x | 4.65x | 15.82x | 1.47% | 16.2B | ||
| 28.91x | 2.69x | 12.02x | 1.49% | 13.68B | ||
| 73.12x | 4.85x | 34.71x | 0.25% | 12.19B | ||
| 21.84x | 2.28x | 11.11x | 0.62% | 11.09B | ||
| 20.3x | 3.02x | 12.22x | 3.59% | 10.51B | ||
| 15.42x | 1.3x | 7.71x | 1.42% | 9.17B | ||
| 23.17x | 1.54x | 13.28x | 0.19% | 7.81B | ||
| 58.01x | 6.9x | 31.06x | 0.17% | 7B | ||
| 69.59x | 0.91x | 7.41x | 2.1% | 5.83B | ||
| Average | 35.55x | 2.95x | 15.30x | 1.25% | 9.4B | |
| Weighted average by Cap. | 35.59x | 3.26x | 16.33x | 1.28% |
Year-on-year evolution of the PER
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- GHC Stock
- Valuation Garofalo Health Care S.p.A.
Select your edition
All financial news and data tailored to specific country editions
